6BGN image
Deposition Date 2017-10-29
Release Date 2018-02-21
Last Version Date 2024-11-06
Entry Detail
PDB ID:
6BGN
Keywords:
Title:
Crystal Structure of 4-Oxalocrotonate Tautomerase After Incubation with 5-Fluoro-2-hydroxy-2,4-pentadienoate
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.51 Å
R-Value Free:
0.16
R-Value Work:
0.11
R-Value Observed:
0.11
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:2-hydroxymuconate tautomerase
Gene (Uniprot):xylH
Chain IDs:A, B, C, D, E, F, G, H, I, J, K, L, M, N, O
Chain Length:60
Number of Molecules:15
Biological Source:Pseudomonas putida
Primary Citation
Inactivation of 4-Oxalocrotonate Tautomerase by 5-Halo-2-hydroxy-2,4-pentadienoates.
Biochemistry 57 1012 1021 (2018)
PMID: 29303557 DOI: 10.1021/acs.biochem.7b00899

Abstact

5-Halo-2-hydroxy-2,4-pentadienoates (5-halo-HPDs) are reportedly generated in the bacterial catabolism of halogenated aromatic hydrocarbons by the meta-fission pathway. The 5-halo-HPDs, where the halogen can be bromide, chloride, or fluoride, result in the irreversible inactivation of 4-oxalocrotonate tautomerase (4-OT), which precedes the enzyme that generates them. The loss of activity is due to the covalent modification of the nucleophilic amino-terminal proline. Mass spectral and crystallographic analysis of the modified enzymes indicates that inactivation of 4-OT by 5-chloro- and 5-bromo-2-hydroxy-2,4-pentadienoate follows a mechanism different from that for the inactivation of 4-OT by 5-fluoro-2-hydroxy-2,4-pentadienoate. The 5-chloro and 5-bromo derivatives undergo 4-OT-catalyzed tautomerization to their respective α,β-unsaturated ketones followed by attack at C5 (by the prolyl nitrogen) with concomitant loss of the halide. For the 5-fluoro species, the presence of a small amount of the α,β-unsaturated ketone could result in a Michael addition of the prolyl nitrogen to C4 followed by protonation at C3. The fluoride is not eliminated. These observations suggest that the inactivation of 4-OT by a downstream metabolite could hamper the efficacy of the pathway, which is the first time that such a bottleneck has been reported for the meta-fission pathway.

Legend

Protein

Chemical

Disease

Primary Citation of related structures